Skip to content

Advertisement

Open Peer Review Reports for: Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
15 Dec 2016 Submitted Original manuscript
17 Jan 2017 Reviewed Reviewer Report - Deep kamal karelia
10 Feb 2017 Reviewed Reviewer Report - Vijay Pandey
27 Feb 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 2
27 Feb 2017 Submitted Manuscript version 2
8 May 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 3
8 May 2017 Submitted Manuscript version 3
16 May 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 4
16 May 2017 Submitted Manuscript version 4
Publishing
19 May 2017 Editorially accepted
6 Jun 2017 Article published 10.1186/s12885-017-3377-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement